RENEE REHRIG: Open Payments
NPI 1689909806 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 93 payments from 21 companies in 2025. Trend: 2023 $1,675 · 2024 $1,855 · 2025 $1,896
Food & beverage: $1,797Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $387 |
| ABBVIE INC. | 18 | $315 |
| Madrigal Pharmaceuticals | 9 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $184 |
| Ardelyx, Inc. | 4 | $120 |
| Phathom Pharmaceuticals, Inc. | 4 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Ipsen Biopharmaceuticals, Inc | 4 | $62 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 2 | $40 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, IBSRELA, RINVOQ, LINZESS, VOQUEZNA, ZENPEP.
Industry payments across PA — which companies pay providers there.
